Op-Ed: For Sale – But Not By Owner

March 28, 2007

Recently, the biotech company LifeCell Corp. announced its financial results for 2006. LifeCell’s revenues – $140.6 million for the year, a 51 percent increase over 2005 – are testament to its remarkable technologies, including a revolutionary skin graft for burn victims. But there may be another reason for LifeCell’s impressive numbers: The company uses human remains to manufacture its most profitable product, but it doesn’t have to compensate the families of the dead. (Hartford Courant)